Location

Rua Câmara Pestana, n.ºs 6, 6-A e 6-B | 1150-082 Lisboa
Phone: 218803101

Otília Vieira

Professor Professor Auxiliar com Agregação
Principal Investigator

Otília Vieira completed her PhD on atherosclerosis prevention under the supervision of Prof. Robert Salvayre (Univ. Paul Sabatier, France) and Prof. Leonor Almeida (Univ. of Coimbra, Portugal). She then pursued postdoctoral training abroad, first investigating host-pathogen interactions with Prof. Sergio Grinstein at the University of Toronto, Canada, and subsequently studying Trans-Golgi Network sorting in polarized cells with Prof. Kai Simons at the Max Planck Institute, Dresden, Germany.

In 2006, she returned to Portugal to establish an independent research group at the Center for Neurosciences and Cell Biology, University of Coimbra, where her work focused on lysosome-mediated plasma membrane resealing, Mycobacterium tuberculosis infection, and the development of surfactants as topical microbicides. In 2014, she was awarded the FCT Investigator grant (Consolidator level) and joined NOVA Medical School, Lisbon. She is currently an Assistant Professor, Principal Investigator of the “Lysosomes and Disease” group, and holds a Habilitation degree. Her research aims to unravel the cellular and molecular mechanisms underlying atherosclerosis and translate these insights into predictive tools and novel therapies for cardiovascular diseases, leading a multidisciplinary team of cardiologists, cell biologists, and biophysical chemists.

She has authored 51 peer-reviewed articles, including first, last, and corresponding author publications in journals such as PNAS, Nature Cell Biology, and Journal of Cell Biology. Her work has been cited over 6,000 times (h-index 32), placing her among the World’s Top 2% of highly cited researchers. She has supervised nine postdocs, nine PhD students, and three MSc students, secured over €2 million in competitive funding, coordinates international collaborations, and serves as Editor for Scientific Reports and Associate Editor for Frontiers in Cell and Developmental Biology. She also holds a provisional international patent.

  • Marques ARA, Ferreira IS, Ribeiro Q, Ferraz MJ, Lopes E, Pinto D, Hall M, Ramalho J, Artola M, Almeida MS, Rodrigues G, Gonçalves PA, Ferreira J, Borbinha C, Marto JP, Viana-Baptista M, Gouveia E Melo R, Pedro LM, Soares MIL, Vaz WLC, Vieira OV, Aerts JMFG. Glucosylated cholesterol accumulates in atherosclerotic lesions and impacts macrophage immune response. J Lipid Res. 2025 Jun;66(6):100825. doi: 10.1016/j.jlr.2025.100825.
  • Calado RDA, Mendes BB, Conniot J, Ravasco JMJM, Sobral D, Ferreira C, Ferreira R, Rodrigues JC, Santos D, Duarte S, Vieira L, Inácio ÂS, Carrêlo H, Vaz WLC, Gomes JP, Nunes A, Conde J, Vieira OV. Preclinical assessment of an antibiotic-free cationic surfactant-based cellulose hydrogel for sexually and perinatally transmitted infections. Matter 7, 2205–2235 June 5, 2024. DOI: 10.1016/j.matt.2024.04.002
  • Domingues N, Marques ARA, Calado RDA, Ferreira IS, Ramos C, Ramalho J, Soares, MIL, Pereira T, Oliveira L, Vicente JR, Wong LH, Simões ICM, Pinho E Melo TMVD, Peden A, Almeida CG, Futter CE, Puertollano R, Vaz WLC, Vieira OV*. Oxidized cholesteryl ester induces exocytosis of dysfunctional lysosomes in lipidotic macrophages. Traffic. 2023 Jul;24(7):284-307. doi: 10.1111/tra.12888.
    *Selected for the journal cover
  • Domingues N, Gaifem J, Matthiesen R, Saraiva DP, Bento L, Marques ARA, Soares MIL, Sampaio J, Klose C, Surma MA, Almeida MS, Rodrigues G, Gonçalves PA, Ferreira J, E Melo RG, Pedro LM, Simons K, Pinho E Melo TMVD, Cabral MG, Jacinto A, Silvestre R, Vaz W, Vieira OV*. Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation. J Lipid Res. 2023 Sep;64(9):100419. doi: 10.1016/j.jlr.2023.100419.
    *Selected for the journal cover
  • Matthiesen R, Lauber C, Sampaio JL, Domingues N, Alves L, Gerl MJ, Almeida MS, Rodrigues G, Araújo Gonçalves P, Ferreira J, Borbinha C, Pedro Marto J, Neves M, Batista F, Viana-Baptista M, Alves J, Simons K, Vaz WLC, Vieira OV*. Shotgun mass spectrometry-based lipid profiling identifies and distinguishes between chronic inflammatory diseases. EBioMedicine. 2021 Jul 23;70:103504. doi: 10.1016/j.ebiom.2021.103504.
    *Commentary in EBioMedicine 70:103526, DOI:https://doi.org/10.1016/j.ebiom.2021.103526.
  • Marques, ARA; Ramos, C; Machado-Oliveira, G; Vieira, OV. Lysosome (Dys)function in Atherosclerosis—A Big Weight on the Shoulders of a Small Organelle. Frontiers in Cell and Developmental Biology Vol. 9, 29 March 2021. doi: 10.3389/fcell.2021.658995.
  • Gerl MJ, Vaz WLC, Domingues N, Klose C, Surma MA, Sampaio JL, Almeida MS, Rodrigues G, Araújo-Gonçalves P, Ferreira J, Borbinha C, Marto JP, Viana-Baptista M, Simons K, Vieira OV. Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients. Sci Rep. 2018 Oct 3;8(1):14764. doi: 10.1038/s41598-018-33116-4.
  • Gibson MS, Domingues N, Vieira OV. Lipid and Non-lipid Factors Affecting Macrophage Dysfunction and Inflammation in Atherosclerosis. Front Physiol. 2018 Jun 26;9:654. doi: 10.3389/fphys.2018.00654.
  • Santarino IB, Viegas MS, Domingues NS, Ribeiro AM, Soares MP, Vieira OV. Involvement of the p62/NRF2 signal transduction pathway on erythrophagocytosis. Sci Rep. 2017 Jul 19;7(1):5812. doi: 10.1038/s41598-017-05687-1
  • N. Domingues, L. Estronca, J. Silva, M. Encarnação, R. Mateus, D. Silva, I. Santarino, M. Saraiva, M. Soares, T. Pinho e Melo, A. Jacinto, W. Vaz and O.V. Vieira. Cholesteryl hemiesters alter lysosome structure and function and induce proinflammatory cytokine production in macrophages. BBA - Molecular and Cell Biology of Lipids. February 2017 1862; 2: 210–220. doi: 10.1016/j.bbalip.2016.10.009
  • 2025: Medal of Merit from the Municipality of Gouveia for dedication to research and for an immeasurable contribution to the field of medicine
  • 2024: Honorable Mention in the scope of the Bluepharma/University of Coimbra Innovation Award 2023 (Otília Vieira)
  • 2023–Present: Listed among the World’s Top 2% of Scientists (Otília Vieira)
  • 2014–2019: FCT Investigator (Consolidator level) (Otília Vieira)
  • 2012: Arrisca C 2011 Award – Business Idea Competition, for the work entitled “Synthesis of New Surfactants and Their Evaluation as Topical Microbicides for Sexually Transmitted Infections”
  • 2011: Ignition Grant from the University of Coimbra, titled “Surfactants in the Prophylaxis of Sexually Transmitted Infections”
  • 2004: Max Planck Postdoctoral Fellowship (Max-Planck-Gesellschaft), Germany
  • 2002: Marie Curie Postdoctoral Fellowship
  • 2002: EMBO Postdoctoral Fellowship
  • 2000–2002: FCT Postdoctoral Fellowship, Ref. No. BPD/22039/99
  • 1997: “Merck Sharp & Dohme” Award (ex-aequo) for the work “Antioxidation of Human Low-Density Lipoproteins (LDL). New Biochemical Mechanisms Mediated by Natural Compounds,” VII Portuguese Atherosclerosis Congress, Luso, Portugal
  • 1997: NATO Science Fellowship to participate in the advanced course “Free Radicals, Oxidative Stress and Antioxidants: Pathological and Physiological Significance,” co-sponsored by FEBS, Antalya, Turkey
  • 1995–1999: FCT PhD Fellowship, Praxis XXI Program, Ref. No. BD/5493/95
  • 1993–1995: JNICT Master’s Fellowship, “Human Resources Mobility” Program, Ref. No. BM/2363/93
  • 1993: “Sociedade Farmacêutica Lusitana” Award, given to the top-ranked graduate of the Bachelor’s degree in Pharmaceutical Sciences at the Faculty of Pharmacy, University of Coimbra

ORCID iD: 0000-0003-4924-1780
Scopus Author Id: 57225361429
Researcher Id O-8660-2017
Google Scholar ID: https://scholar.google.com/citations?user=OjPzGY8AAAAJ&hl=pt-PT
CIÊNCIA ID: 5D18-B71A-9E1A